BRCA1 and neoplasm: Moreover, after cisplatin treatment, the MCF7-H and MCF7-J cybrids showed 3.15-fold and 2.78-fold increase in BRCA1 transcription, respectively, which may contribute to the inhibition of tumor growth from the treatment.